Market revenue in 2023 | USD 25.2 million |
Market revenue in 2030 | USD 44.4 million |
Growth rate | 8.4% (CAGR from 2023 to 2030) |
Largest segment | Project and data management |
Fastest growing segment | Reading and Analytical Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management |
Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Project and data management was the largest segment with a revenue share of 28.97% in 2023. Horizon Databook has segmented the Thailand clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.
Presence of universal healthcare system, world-class infrastructure, and national policies supporting clinical research industry is expected to drive the market growth in Thailand. The Deloitte Access Economics was commissioned by Pharmaceutical Research and Manufacturers Association (PReMA) in Thailand to understand the economic and healthcare benefits in the country of conducting clinical trials.
According to the study conducted by Pharmaceutical Research and Manufacturers Association (PReMA), around USD 320 million was spent on Thai clinical trials in 2015, 75% of which was mainly spent on Phase III trials.
Furthermore, low cost of conducting clinical trials in Thailand is expected to increase focus of the country on clinical trial industry. Therefore, growing focus of the country on conducting clinical trials is expected to propel the overall market growth during the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand clinical trial imaging market , including forecasts for subscribers. This country databook contains high-level insights into Thailand clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account